… inversed association between colorectal cancer risk and hormone replacement therapy (OR,
0.62; 95% CI, 0.54–0.75), which was more prominent among women having multiple HRT …

… lower all-cause and colorectal cancer mortality in colorectal cancer survivors. Findings for
… in colorectal cancer risk in women [5]. In addition to the well-documented chemoprevention …

… therapeutic/medical cancer prevention The concept of ‘chemoprevention’ as an
approach to reducing cancer … Interestingly, it has been recognized that use of the term ‘chemoprevention’ …

… Nevertheless, based on these findings alone we do not simply advocate the use of MHT
as a chemoprevention intervention in those with high genetic risk for CRC because of its …

The clinical benefits of hormone replacement therapy in women have to be carefully … relates
to risks associated with various forms of female oncology. Because of conflicting reports, …

… Based on this evidence, the correlation between hormone replacement therapy and CRC …
an inverse association between hormone use and the risk of both colorectal adenomas [232,…

… the incidence and mortality of cancers, particularly that of colorectal cancer (CRC). … use of
chemoprevention agents. Among them, aspirin is the most promising. Aspirin acts in colorectal …

… , breast and colon cancers, are routinely used in clinics and proven to reduce cancer mortality.
While … Table 1 summarizes the chemopreventive agents that are discussed in this article. …

… estrogen formulations in hormone replacement therapy (HRT) on post-menopausal women
… tool for targeted endocrine remedies as well as for combined chemopreventive approaches …

Full article: Prediagnostic use of estrogen-only therapy is associated with improved colorectal
cancer survival in menopausal women: a Swedish population-based cohort study Skip to …